Human Neutrophil Elastase Degrades SPLUNC1 and Impairs Airway Epithelial Defense against Bacteria
Open Access
- 31 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5), e64689
- https://doi.org/10.1371/journal.pone.0064689
Abstract
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a significant cause of mortality of COPD patients, and pose a huge burden on healthcare. One of the major causes of AECOPD is airway bacterial (e.g. nontypeable Haemophilus influenzae [NTHi]) infection. However, the mechanisms underlying bacterial infections during AECOPD remain poorly understood. As neutrophilic inflammation including increased release of human neutrophil elastase (HNE) is a salient feature of AECOPD, we hypothesized that HNE impairs airway epithelial defense against NTHi by degrading airway epithelial host defense proteins such as short palate, lung, and nasal epithelium clone 1 (SPLUNC1). Recombinant human SPLUNC1 protein was incubated with HNE to confirm SPLUNC1 degradation by HNE. To determine if HNE-mediated impairment of host defense against NTHi was SPLUNC1-dependent, SPLUNC1 protein was added to HNE-treated primary normal human airway epithelial cells. The in vivo function of SPLUNC1 in NTHi defense was investigated by infecting SPLUNC1 knockout and wild-type mice intranasally with NTHi. We found that: (1) HNE directly increased NTHi load in human airway epithelial cells; (2) HNE degraded human SPLUNC1 protein; (3) Recombinant SPLUNC1 protein reduced NTHi levels in HNE-treated human airway epithelial cells; (4) NTHi levels in lungs of SPLUNC1 knockout mice were increased compared to wild-type mice; and (5) SPLUNC1 was reduced in lungs of COPD patients. Our findings suggest that SPLUNC1 degradation by neutrophil elastase may increase airway susceptibility to bacterial infections. SPLUNC1 therapy likely attenuates bacterial infections during AECOPD.This publication has 50 references indexed in Scilit:
- Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease SeverityPLOS ONE, 2012
- IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor–associated kinase MJournal of Allergy and Clinical Immunology, 2012
- Sustained expression of PGC-1 in the rat nigrostriatal system selectively impairs dopaminergic functionHuman Molecular Genetics, 2012
- Profiling of Sputum Inflammatory Mediators in Asthma and Chronic Obstructive Pulmonary DiseaseRespiration, 2011
- SPLUNC1 Promotes Lung Innate Defense Against Mycoplasma pneumoniae Infection in MiceThe American Journal of Pathology, 2011
- SPLUNC1 regulation in airway epithelial cells: role of toll-like receptor 2 signalingRespiratory Research, 2010
- A human surfactant peptide-elastase inhibitor construct as a treatment for emphysemaProceedings of the National Academy of Sciences of the United States of America, 2010
- Comparison of Proteomic and Transcriptomic Profiles in the Bronchial Airway Epithelium of Current and Never SmokersPLOS ONE, 2009
- PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of DementiaArchives of Neurology, 2009
- Association between markers of emphysema and more severe chronic obstructive pulmonary diseaseThorax, 2006